Bioviz is developing various monoclonal antibodies. Bioviz is keen on bringing mAbs at affordable prices with good efficacy and quality. Few products are in R&D and animal toxicology studies.
Products in Pipeline
- Omalizumab
- Ustekinumab
- Nivolumab
- Adalimumab
- Trastuzumab
